127 related articles for article (PubMed ID: 27834470)
21. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
22. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.
Zhang W; Ren SC; Shi XL; Liu YW; Zhu YS; Jing TL; Wang FB; Chen R; Xu CL; Wang HQ; Wang HF; Wang Y; Liu B; Li YM; Fang ZY; Guo F; Lu X; Shen D; Gao X; Hou JG; Sun YH
Prostate; 2015 May; 75(6):653-61. PubMed ID: 25597901
[TBL] [Abstract][Full Text] [Related]
23. Chronic inflammation of the prostate type IV with respect to risk of prostate cancer.
Porcaro AB; Rubilotta E; Petrozziello A; Ghimenton C; Migliorini F; Zecchini Antoniolli S; Lacola V; Monaco C; Curti P; Cavalleri S; Pianon R; Artibani W
Arch Ital Urol Androl; 2014 Sep; 86(3):208-11. PubMed ID: 25308586
[TBL] [Abstract][Full Text] [Related]
24. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
[TBL] [Abstract][Full Text] [Related]
25. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
Ferro M; Bruzzese D; Perdonà S; Mazzarella C; Marino A; Sorrentino A; Di Carlo A; Autorino R; Di Lorenzo G; Buonerba C; Altieri V; Mariano A; Macchia V; Terracciano D
Clin Chim Acta; 2012 Aug; 413(15-16):1274-8. PubMed ID: 22542564
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
De Nunzio C; Lombardo R; Leonardo C; Franco G; Gacci M; Presicce F; Cancrini F; Tubaro A
Urol Oncol; 2014 Jan; 32(1):35.e9-13. PubMed ID: 23510864
[TBL] [Abstract][Full Text] [Related]
27. Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study.
Cicione A; Cantiello F; De Nunzio C; Tubaro A; Damiano R
Urol Oncol; 2014 Jan; 32(1):28.e27-31. PubMed ID: 23273912
[TBL] [Abstract][Full Text] [Related]
28. Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.
Yilmaz H; Ustuner M; Ciftci S; Yavuz U; Ozkan TA; Dillioglugil O
Int Braz J Urol; 2014; 40(5):613-9. PubMed ID: 25498272
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
30. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
[TBL] [Abstract][Full Text] [Related]
31. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
[TBL] [Abstract][Full Text] [Related]
32. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
[TBL] [Abstract][Full Text] [Related]
33. Defining prostate cancer risk before prostate biopsy.
Pal RP; Maitra NU; Mellon JK; Khan MA
Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
[TBL] [Abstract][Full Text] [Related]
34. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
[TBL] [Abstract][Full Text] [Related]
35. Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review.
Pepe P; Panella P; D'Arrigo L; Savoca F; Pennisi M; Aragona F
Oncology; 2006; 70(2):81-9. PubMed ID: 16601365
[TBL] [Abstract][Full Text] [Related]
36. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
[TBL] [Abstract][Full Text] [Related]
37. PSA density improves prediction of prostate cancer.
Verma A; St Onge J; Dhillon K; Chorneyko A
Can J Urol; 2014 Jun; 21(3):7312-21. PubMed ID: 24978363
[TBL] [Abstract][Full Text] [Related]
38. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
[TBL] [Abstract][Full Text] [Related]
39. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
[TBL] [Abstract][Full Text] [Related]
40. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]